Culture Apothecary with Alex Clark Mifepristone & Women’s Health: What the Headlines Leave Out | Dr. Christina Francis, MD
Feb 20, 2026
Dr. Christina Francis, board-certified OB/GYN and CEO of the American Association of Pro-Life OB/GYNs, discusses medication abortion trends, risks of mifepristone and misoprostol, and gaps in reporting and regulation. She covers online distribution, real-world bleeding and complications, environmental concerns about fetal tissue, and debates over safeguards and clinical guidance.
AI Snips
Chapters
Transcript
Episode notes
Post-Dobbs Shift And Misinformation
- The Dobbs decision exposed widespread medical misinformation and conflated abortion with other pregnancy care issues.
- Christina Francis says pill access and remote dispensing, not legality, largely drive rising abortion numbers.
How The Pill Works Biologically
- Mifepristone blocks progesterone and starves the embryo by disrupting maternal-fetal blood flow.
- Misoprostol then induces strong contractions and often heavy bleeding to expel the pregnancy.
Safety Messaging Versus Reality
- Abortion advocates portray the pill as as safe and simple, but Francis says many women experience heavier, prolonged bleeding.
- She emphasizes lack of informed consent, especially when pills are mailed without clinician interaction.